
Sun Jae Yoo
Examiner (ID: 4021, Phone: (571)272-9074 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1622, 1609, 1626, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1172 |
| Pending Applications | 219 |
| Abandoned Applications | 564 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16389520
[patent_doc_number] => 20200330461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => Imidazopyrazine Inhibitors of Bruton's Tyrosine Kinase
[patent_app_type] => utility
[patent_app_number] => 16/917222
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16917222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/917222 | Imidazopyrazine inhibitors of Bruton's tyrosine kinase | Jun 29, 2020 | Issued |
Array
(
[id] => 19423197
[patent_doc_number] => 12082581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Acrylate derivative, use and production intermediate compound of the same
[patent_app_type] => utility
[patent_app_number] => 17/623129
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41359
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1586
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623129 | Acrylate derivative, use and production intermediate compound of the same | Jun 25, 2020 | Issued |
Array
(
[id] => 17043787
[patent_doc_number] => 11096947
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Combination products with tyrosine kinase inhibitors and their use
[patent_app_type] => utility
[patent_app_number] => 16/905161
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22064
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16905161
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/905161 | Combination products with tyrosine kinase inhibitors and their use | Jun 17, 2020 | Issued |
Array
(
[id] => 18384476
[patent_doc_number] => 11655245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Oxadiazole transient receptor potential channel inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/903020
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35701
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16903020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/903020 | Oxadiazole transient receptor potential channel inhibitors | Jun 15, 2020 | Issued |
Array
(
[id] => 18109444
[patent_doc_number] => 20230002324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/618428
[patent_app_country] => US
[patent_app_date] => 2020-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618428 | NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | Jun 12, 2020 | Abandoned |
Array
(
[id] => 17792274
[patent_doc_number] => 20220251365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => VISCOUS COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/622481
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622481
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622481 | VISCOUS COMPOSITION | Jun 11, 2020 | Pending |
Array
(
[id] => 16512794
[patent_doc_number] => 20200392052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => HYPERGOLIC CO-CRYSTAL MATERIAL AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/900241
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900241
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900241 | Hypergolic co-crystal material and method of use thereof | Jun 11, 2020 | Issued |
Array
(
[id] => 16310712
[patent_doc_number] => 20200289450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/887946
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/887946 | METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS | May 28, 2020 | Abandoned |
Array
(
[id] => 16525140
[patent_doc_number] => 20200399220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => 3,5-DIARYLIDENYL-N-SUBSTITUTED-PIPERID-4-ONE-DERIVED INHIBITORS OF STAT3 PATHWAY ACTIVITY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/929736
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15929736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/929736 | 3,5-diarylidenyl-n-substituted-piperid-4-one-derived inhibitors of Stat3 pathway activity and uses thereof | May 18, 2020 | Issued |
Array
(
[id] => 17687623
[patent_doc_number] => 20220194915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR EXTRACTING AND SEPARATING DIHYDROMYRICETIN FROM RATTAN TEA
[patent_app_type] => utility
[patent_app_number] => 17/599823
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599823 | Method for extracting and separating dihydromyricetin from rattan tea | May 7, 2020 | Issued |
Array
(
[id] => 16421845
[patent_doc_number] => 20200347043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => MODULATORS OF THE INTEGRATED STRESS PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/863747
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -95
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863747 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Apr 29, 2020 | Pending |
Array
(
[id] => 16425302
[patent_doc_number] => 20200350500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/853022
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 362
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853022 | Compound and photoelectric device, image sensor and electronic device including the same | Apr 19, 2020 | Issued |
Array
(
[id] => 16297667
[patent_doc_number] => 20200283390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => METHOD FOR PRODUCING PITAVASTATIN CALCIUM
[patent_app_type] => utility
[patent_app_number] => 16/851402
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851402
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851402 | Method for producing pitavastatin calcium | Apr 16, 2020 | Issued |
Array
(
[id] => 16221208
[patent_doc_number] => 20200246324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/852008
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16852008
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/852008 | Pharmaceutical compositions | Apr 16, 2020 | Issued |
Array
(
[id] => 17052097
[patent_doc_number] => 20210261531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => NITROGEN-HETEROCYCLIC COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS
[patent_app_type] => utility
[patent_app_number] => 16/847534
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847534
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847534 | Nitrogen-heterocyclic compound, display panel and display apparatus | Apr 12, 2020 | Issued |
Array
(
[id] => 18792636
[patent_doc_number] => 11826369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Targeting the TLK1/NEK1 axis in prostate cancer
[patent_app_type] => utility
[patent_app_number] => 16/834061
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 90
[patent_no_of_words] => 14915
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/834061 | Targeting the TLK1/NEK1 axis in prostate cancer | Mar 29, 2020 | Issued |
Array
(
[id] => 19904113
[patent_doc_number] => 12281109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes
[patent_app_type] => utility
[patent_app_number] => 17/598342
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15635
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598342 | Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes | Mar 29, 2020 | Issued |
Array
(
[id] => 20213486
[patent_doc_number] => 12410126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Process for making Siponimod and intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 17/599868
[patent_app_country] => US
[patent_app_date] => 2020-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4619
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599868 | Process for making Siponimod and intermediate thereof | Mar 28, 2020 | Issued |
Array
(
[id] => 21009775
[patent_doc_number] => 12746246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-29
[patent_title] => Compositions and methods for treating age-related macular degeneration
[patent_app_type] => utility
[patent_app_number] => 17/598660
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 3518
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598660
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598660 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION | Mar 26, 2020 | Pending |
Array
(
[id] => 18311276
[patent_doc_number] => 20230115176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Complement Modulators and Related Methods
[patent_app_type] => utility
[patent_app_number] => 17/442246
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442246 | Complement Modulators and Related Methods | Mar 26, 2020 | Abandoned |